Literature DB >> 30431386

Adipocytokine Involvement in Innate Immune Mechanisms.

Paulina Żelechowska1, Elżbieta Kozłowska1, Joanna Pastwińska1,2, Justyna Agier1, Ewa Brzezińska-Błaszczyk1.   

Abstract

The innate immune response is defined as an immensely complex and sophisticated process aimed at defending the organism against any disturbance in the body homeostasis, including invading pathogens. It requires a close cooperation of a vast amount of different cell types, recognized as inflammatory migrating cells, as well as stationary cells that form tissues. Moreover, innate immune mechanisms require an efficient functioning of various humoral components that exert a significant impact on physiological and pathological processes. Apart from commonly mentioned humoral factors, this group also includes a family of proteins known as adipocytokines that may act as pro- or anti-inflammatory agents or act both ways. Leptin, predominantly characterized as a proinflammatory adipokine, plays a crucial role in endothelium remodeling and regulation, as well as in cell survival and production of numerous cytokines. Adiponectin, similar to leptin, acts on the endothelial cells and the phagocytic properties of immune cells; however, it exerts an anti-inflammatory impact. Resistin has a documented role in the control of angiogenesis and stimulation of proinflammatory mediator generation and release. Furthermore, there are adipokines, ie, visfatin and chemerin, whose participation in the inflammatory processes is ambiguous. This review focuses on the current knowledge on the extensive role of selected adipokines in innate immune response.

Entities:  

Keywords:  adipocytokines; adiponectin; chemerin; leptin; resistin; visfatin

Mesh:

Substances:

Year:  2018        PMID: 30431386     DOI: 10.1089/jir.2018.0102

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  8 in total

1.  Adipocytokines leptin and adiponectin function as mast cell activity modulators.

Authors:  Paulina Żelechowska; Ewa Brzezińska-Błaszczyk; Magdalena Wiktorska; Sylwia Różalska; Sebastian Wawrocki; Elżbieta Kozłowska; Justyna Agier
Journal:  Immunology       Date:  2019-07-10       Impact factor: 7.397

2.  Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa.

Authors:  Marcos A González-López; J Gonzalo Ocejo-Viñals; Cristina Mata; Diego Díaz; Sandra Guiral; Virginia Portilla; Alfonso Corrales; M Carmen González-Vela; Miguel A González-Gay; Ricardo Blanco; José L Hernández
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

Review 3.  Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications.

Authors:  Katarzyna Zorena; Olga Jachimowicz-Duda; Daniel Ślęzak; Marlena Robakowska; Małgorzata Mrugacz
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

4.  Rat Milk and Plasma Immunological Profile throughout Lactation.

Authors:  Blanca Grases-Pintó; Mar Abril-Gil; Paulina Torres-Castro; Margarida Castell; María J Rodríguez-Lagunas; Francisco J Pérez-Cano; Àngels Franch
Journal:  Nutrients       Date:  2021-04-11       Impact factor: 5.717

5.  Cardioprotective effects of enteral vs. parenteral lactoferrin administration on myocardial ischemia-reperfusion injury in a rat model of stunned myocardium.

Authors:  Keisuke Omiya; Yosuke Nakadate; Takeshi Oguchi; Tamaki Sato; Toru Matsuoka; Masako Abe; Akiko Kawakami; Takashi Matsukawa; Hiroaki Sato
Journal:  BMC Pharmacol Toxicol       Date:  2022-10-14       Impact factor: 2.605

6.  Association of Adipocytokines With Carotid Intima Media Thickness and Arterial Stiffness in Obstructive Sleep Apnea Patients.

Authors:  Fan Song; Juanjuan Zou; Zhiyuan Song; Huajun Xu; Yinjun Qian; Huaming Zhu; Suru Liu; Jian Guan; Jie Chen; Hongliang Yi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-02       Impact factor: 5.555

7.  Chemerin enhances the adhesion and migration of human endothelial progenitor cells and increases lipid accumulation in mice with atherosclerosis.

Authors:  Jue Jia; Fan Yu; Yuyun Xiong; Weiping Wei; Hong Ma; Fulvio Nisi; Xu Song; Ling Yang; Dong Wang; Guoyue Yuan; Hongwen Zhou
Journal:  Lipids Health Dis       Date:  2020-09-20       Impact factor: 3.876

8.  Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.

Authors:  Ling Li; Tiantian Wei; Shuyun Liu; Chengshi Wang; Meng Zhao; Yanhuan Feng; Liang Ma; Yanrong Lu; Ping Fu; Jingping Liu
Journal:  J Cell Mol Med       Date:  2020-12-06       Impact factor: 5.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.